Langdorp, Belgium

Ingrid Van Der Auwera




Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ingrid Van Der Auwera

Introduction

Ingrid Van Der Auwera is a notable inventor based in Langdorp, Belgium. She has made significant contributions to the field of neurodegenerative disease treatment through her innovative research and development of new compounds.

Latest Patents

Ingrid holds a patent for "Thiadiazole derivatives for the treatment of neurodegenerative diseases." This invention specifically focuses on substituted 1,2,4-thiadiazole derivatives that are utilized in treating various α-synucleopathies, including Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy, and Alzheimer's disease. The patent also outlines various methods for producing these substituted derivatives.

Career Highlights

Ingrid is associated with Nv Remynd, a company dedicated to advancing therapeutic solutions for neurodegenerative conditions. Her work has been instrumental in developing new treatment options that could potentially improve the quality of life for patients suffering from these debilitating diseases.

Collaborations

Ingrid collaborates with talented professionals in her field, including Gerard Griffioen and Kristel Marie Edith Coupet. These partnerships enhance her research efforts and contribute to the innovative environment at Nv Remynd.

Conclusion

Ingrid Van Der Auwera's contributions to the field of neurodegenerative disease treatment through her patented inventions highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical science and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…